The aim of this study was to evaluate if the prognostic impact of coffee consumption overall, and especially in tamoxifen-treated breast cancer patients, was partly mediated through associations with tumor-specific IGF1R protein expression and the patients’ BMI. This evidence concerns the gene IGF1R and breast cancer.